NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization26.41 mln
Float19.88 mln
Earnings Date04/30/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
8
/ 100
Severely lagging
Debt / Equity
0.31
Low leverage
ROE
-107
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
ABVC BioPharma is a California-based company working to bring new treatments to patients with serious conditions that currently have few good options. The company has a broad pipeline of drugs and medical devices moving through clinical trials, targeting areas such as breast cancer, depression, ADHD, lung cancer, pancreatic cancer, and eye conditions. ABVC advances its work through partnerships with several life sciences organizations, combining shared resources and expertise to move its products closer to market.
